Blog
Saphris® Lawyer & Lawsuit
Saphris (asenapine maleate) is a prescription antipsychotic medication intended to be administered in the treatment of schizophrenia and bipolar disorders in adults. However the U.S. Food and Drug Administration (FDA) recently acknowledged an influx of adverse events associated with the use of Saphris. Saphris treatment may coincide with severe, life-threatening type I hypersensitivity allergic…
Paroxetine Birth Defects Lawyer & Lawsuit
According to recent studies, mothers who use Paroxetine during pregnancy are twice as likely to give birth to children with extremely serious birth defects. Paroxetine Lawsuit Update: On July 4, 2011, a study published in the Archives of General Psychiatry announced that children born to mothers who took an SSRI antidepressant like Paroxetine during…
Popular Bisphosphonates May Cause Esophageal Cancer
According to recent data obtained from the U.K. General Practice Research Database, oral osteoporosis medications known as bisphosphonates may be responsible for an increased risk of esophageal cancer. In the wake of these findings, the U.S. Food and Drug Administration (FDA) has indicated that they intend to launch an extensive campaign to determine the…
Increased Risk of Blood Clots in Non-Pill Contraceptives
Most women of reproductive age in the United States have used at least one method birth control. Between 2006–2008, 99% of women who had ever had sexual intercourse had used at least one form of contraception. The most popular method of birth control was the oral contraceptive pill, used by 10.7 million women in…
U.S. Regulators Attempt to Eliminate Exposed Window Cord Injuries
In a recent turn of events, the makers of window blind products have become the subject of intense criticism. Indicated by industry established standards, window blind makers’ safety practices demonstrate a propensity for negligence. Subsequently, manufacturers have begun to adopt less-stringent safety policies while simultaneously ignoring the demands of federal regulators to eliminate exposed…
Canadian Study Quantifies Actos Bladder Cancer Risk
Having nearly eclipsed $5 billion in sales just two years ago, Actos (generic: pioglitazone) has established itself as the unquestionable flagship product of Takeda Pharmaceuticals. Accordingly, Actos has assisted in the treatment of type 2 diabetes for millions of patients around the world. Of significant concern, however, are previous studies that have established an…
Secret Archives Files Provide Incriminating Evidence Against Philadelphia’s Archdiocese
Scandal has once again rocked the foundation of America’s largest religious denomination. Five members of the Philadelphia archdiocese are on trial, for what many are referring to as crimes against humanity. Four out of the five men have been accused of committing sexually abusive crimes against children of the perish. However, perhaps even more…
Tumor Necrosis Factor-alpha (TNFα) Blockers Lawyer & Lawsuit
Tumor necrosis factor-alpha blockers, otherwise known as TNFα inhibitors, are used to treat a variety of autoimmune disorders including: Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, and juvenile idiopathic arthritis. Unfortunately, TNFα treatment has become the subject of intense scrutiny in the healthcare community. Because the pharmacodynamics of TNFα…